2023 Form 5500 filing — Lifemine Therapeutics 401(K) Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241008082556NAL0017281041001) for Lifemine Therapeutics 401(K) Plan, reported by Lifemine Therapeutics, Inc. under EIN 81-3783202 and plan number 001. It reports 160 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials).

Form 5500 2 · 2023

Filing snapshot

Net assets (EOY)$5.5MReported net assets$5,488,054
Participants160
Provider compensationNone reported
Schedules filedSchedule HLoaded schedules
EFAST2 acknowledgement
20241008082556NAL0017281041001
Plan sponsor
Lifemine Therapeutics, Inc.
EIN
81-3783202
Plan number
001
Location
Cambridge, MA
Received date
not reported in the loaded dataset
How to read this filing
  • This is a single annual Form 5500 filing, identified by its EFAST2 acknowledgement id.
  • Schedule chips (Sch H / I / C) show which schedules this filing includes.
  • Net assets = total assets minus total liabilities (Schedule H/I).
  • Fields a filing did not report are labeled not reported in the loaded dataset — never estimated.
  • For the plan's full history, open the plan profile.
Schedule H · 2023

Reported financial snapshot

Reported figures as filed, in whole dollars. Only fields the filing reports are shown.

Reported balance (end of year)$5.5M total assets
Net assets$5.5MLiabilities$0
Money in vs. money out
Total income / additions$2.6M
Total expenses$794.8K
Benefits paid / distributions$764.6K
Contributions
Employer$524.9K
Participant$1.1M
Full reported line items
Total assets (EOY)
$5,488,054
Total liabilities (EOY)
$0
Net assets (EOY)
$5,488,054
Employer contributions
$524,879
Participant contributions
$1,133,560
Total income / additions
$2,618,843
Benefits paid
$764,583
Administrative expenses
$29,232
Total expenses
$794,842
Net increase / (decrease)
$1,824,001

What to inspect next

Frequently asked questions

What does EFAST2 acknowledgement 20241008082556NAL0017281041001 cover?
It is the 2023 Form 5500 filing for Lifemine Therapeutics 401(K) Plan, reported by Lifemine Therapeutics, Inc. (EIN 81-3783202).
Which Form 5500 schedules are attached to this 2023 filing?
Attached schedules in the loaded dataset include Schedule H (large plan financials).

Related Form 5500 pages